Pittsburgh Biotech Company Announces Plans To Liquidate Assets For Shareholder Distribution

NeuBase Therapeutics: The Dissolution, Liquidation, and What It Means for Shareholders

As an investor it's important to stay updated with major news. Get real-time stock market alerts, news, and research by creating an account here.

In a surprising turn of events, NeuBase Therapeutics, Inc., a renowned biotech firm based in Pittsburgh, has announced plans to dissolve and liquidate its assets, distributing them to shareholders. This signifi…